Cambridge Investment Research Advisors
FLGT icon

Cambridge Investment Research Advisors’s Fulgent Genetics FLGT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,130
Closed -$264K – 3344
2023
Q4 		$264K Sell
9,130
-1,442
-14% -$38.6K ﹤0.01% 2689
2023
Q3 		$283K Buy
10,572
+693
+7% +$23.7K ﹤0.01% 2535
2023
Q2 		$366K Sell
9,879
-421
-4% -$14.7K ﹤0.01% 2373
2023
Q1 		$322K Buy
10,300
+427
+4% +$13.7K ﹤0.01% 2428
2022
Q4 		$294K Sell
9,873
-1,915
-16% -$68.5K ﹤0.01% 2450
2022
Q3 		$449K Buy
11,788
+1,187
+11% +$59.5K ﹤0.01% 2021
2022
Q2 		$578K Buy
10,601
+151
+1% +$8.3K ﹤0.01% 1854
2022
Q1 		$652K Sell
10,450
-14
-0.1% -$922 ﹤0.01% 1897
2021
Q4 		$1.05M Buy
10,464
+4,521
+76% +$397K ﹤0.01% 1549
2021
Q3 		$535K Sell
5,943
-1,358
-19% -$123K ﹤0.01% 1997
2021
Q2 		$673K Buy
7,301
+1,297
+22% +$104K ﹤0.01% 1826
2021
Q1 		$580K Buy
+6,004
New +$620K ﹤0.01% 1794

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cambridge Investment Research Advisors's FLGT Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 9,130 shares — an estimated $264K sold.

Cambridge Investment Research Advisors first reported a position in FLGT in Q1 2021 and held it in 12 quarters. The position peaked at $1.05M in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 9,130 Fulgent Genetics shares in Q1 2024, an estimated $264K.
  • Cambridge Investment Research Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Fulgent Genetics position peaked at $1.05M in Q4 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.